Corifollitropin alfa
- Generic Name
- Corifollitropin alfa
- Brand Names
- Elonva
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 195962-23-3
- Unique Ingredient Identifier
- T7K20Y2GWY
- Background
Corifollitropin alfa, also known as Elonva is used in women undergoing fertility treatment to stimulate the development of more than one mature egg (oocyte) at a time in the ovaries. This drug used together with a gonadotropin-releasing hormone (GnRH) antagonist, a type of medicine also used in fertility treatments. Elonva is available only by prescription ....
- Indication
Controlled ovarian stimulation in cases of women who are undergoing fertility treatment to stimulate the development of more than one mature egg simultaneously in the ovaries in combination with a gonadotrophin-releasing hormone (GnRH) antagonist (a type of medicine also used in fertility treatments).
- Associated Conditions
- -
- Associated Therapies
- -
Type of Gonadotropin and Embryo Kinetics of Development
- First Posted Date
- 2015-03-30
- Last Posted Date
- 2022-08-11
- Lead Sponsor
- IVI Madrid
- Target Recruit Count
- 201
- Registration Number
- NCT02402192
Corifollitropin Alfa Versus Daily rFSH in the Controlled Ovarian Stimulation of Poor Responders
- First Posted Date
- 2014-10-02
- Last Posted Date
- 2016-01-18
- Lead Sponsor
- IVI Sevilla
- Target Recruit Count
- 26
- Registration Number
- NCT02254928
- Locations
- 🇪🇸
IVI Barcelona, Barcelona, Spain
🇪🇸IVI Madrid, Madrid, Spain
🇪🇸IVI Sevilla, Seville, Spain
Corifollitropin Alfa Application in PCOS Patients
- First Posted Date
- 2014-08-13
- Last Posted Date
- 2014-08-13
- Lead Sponsor
- Shin Kong Wu Ho-Su Memorial Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT02215135
- Locations
- 🇨🇳
Department of Obstetrics and Gynecology, Shin-Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan
Use of Corifolitropin Alfa in Oocyte Donors
- Conditions
- Interventions
- First Posted Date
- 2014-08-11
- Last Posted Date
- 2015-07-17
- Lead Sponsor
- IVI Madrid
- Target Recruit Count
- 300
- Registration Number
- NCT02213627
- Locations
- 🇪🇸
IVI Madrid, Madrid, Spain
Corifollitropin Alfa Compared to Daily rFSH in Poor Responders Undergoing ICSI
- First Posted Date
- 2014-01-28
- Last Posted Date
- 2014-05-14
- Lead Sponsor
- Aristotle University Of Thessaloniki
- Target Recruit Count
- 80
- Registration Number
- NCT02046655
- Locations
- 🇬🇷
Unit for Human Reproduction, 1st Dept of Obstetrics and Gynaecology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece
Corifollitropin Alfa Followed by Menotropin for Poor Ovarian Responders Trial
- Conditions
- Interventions
- First Posted Date
- 2013-03-22
- Last Posted Date
- 2016-06-23
- Lead Sponsor
- Universitair Ziekenhuis Brussel
- Target Recruit Count
- 150
- Registration Number
- NCT01816321
- Locations
- 🇧🇪
Universitair Ziekenhuis Brussel, Brussels, Belgium
🇻🇳University of Medicine and Pharmacy of Ho Chi Minh City, Ho Chi Minh City, Vietnam
Treatment of Poor Ovarian Responders With Corifollitropin Alfa Followed by hpHMG in a Short GnRH Agonist Protocol
- Conditions
- Interventions
- First Posted Date
- 2012-11-22
- Last Posted Date
- 2013-05-09
- Lead Sponsor
- Universitair Ziekenhuis Brussel
- Target Recruit Count
- 51
- Registration Number
- NCT01732068
- Locations
- 🇧🇪
Centre for Reproductive Medicine UZ Brussel, Brussels, Belgium
A Study of the Efficacy and Safety of Corifollitropin Alfa (MK-8962) in Combination With Human Chorionic Gonadotropin (hCG) in Adult Men With Hypogonadotropic Hypogonadism (HH) (P07937)
- Conditions
- Interventions
- First Posted Date
- 2012-10-18
- Last Posted Date
- 2024-05-24
- Lead Sponsor
- Organon and Co
- Target Recruit Count
- 18
- Registration Number
- NCT01709331
D2 Versus D4 Corifollitropin Alfa in GnRH Antagonists
- First Posted Date
- 2012-07-04
- Last Posted Date
- 2014-12-03
- Lead Sponsor
- Universitair Ziekenhuis Brussel
- Target Recruit Count
- 67
- Registration Number
- NCT01633580
- Locations
- 🇧🇪
UZ Brussel, Jette, Belgium
A Post Marketing Observational Study of the Safety and Efficacy of Elonva (Corifollitropin Alfa) in General Practice (P08165)
- First Posted Date
- 2011-08-03
- Last Posted Date
- 2022-02-03
- Lead Sponsor
- Organon and Co
- Target Recruit Count
- 472
- Registration Number
- NCT01408615
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.